We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATHN
1126
DELISTED
Athenahealth, Inc.
ATHN
| $2.59M | 0.01% |
+19,448
| New | +$2.49M |
|
|
LPNT
1127
DELISTED
LifePoint Health, Inc.
LPNT
| $2.58M | 0.01% |
51,808
+8,600
| +20% | +$427K |
|
1128
La-Z-Boy
LZB
$1.59B
| $2.58M | 0.01% |
82,649
-119,624
| -59% | -$3.45M |
|
1129
CytomX Therapeutics
CTMX
$705M
| $2.58M | 0.01% |
122,100
+69,200
| +131% | +$1.43M |
|
|
NSA
1130
DELISTED
National Storage Affiliates Trust
NSA
| $2.56M | 0.01% |
94,100
+17,400
| +23% | +$448K |
|
|
TIVO
1131
DELISTED
Tivo Inc
TIVO
| $2.56M | 0.01% |
164,351
-185,592
| -53% | -$3.21M |
|
1132
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
| $2.55M | 0.01% |
300,482
-18,494
| -6% | -$157K |
|
1133
CRA International
CRAI
$1.1B
| $2.55M | 0.01% |
56,793
+11,447
| +25% | +$502K |
|
1134
Ecolab
ECL
$75.6B
| $2.55M | 0.01% |
19,029
-8,900
| -32% | -$1.18M |
|
1135
Upbound Group
UPBD
$1.19B
| $2.54M | 0.01% |
229,287
+100
| +0% | +$1.09K |
|
|
BGFV
1136
DELISTED
Big 5 Sporting Goods
BGFV
| $2.54M | 0.01% |
334,167
-38,714
| -10% | -$279K |
|
1137
SandRidge Energy
SD
$510M
| $2.52M | 0.01% |
119,700
+61,100
| +104% | +$1.14M |
|
1138
Fidus Investment
FDUS
$737M
| $2.52M | 0.01% |
165,912
+47,676
| +40% | +$768K |
|
|
GHDX
1139
DELISTED
Genomic Health, Inc.
GHDX
| $2.51M | 0.01% |
73,400
-18,874
| -20% | -$602K |
|
|
BNCL
1140
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $2.5M | 0.01% |
151,900
-47,762
| -24% | -$793K |
|
1141
Santander
BSBR
$39.7B
| $2.49M | 0.01% |
268,517
-54,601
| -17% | -$484K |
|
1142
CAE Inc. Common Shares
CAE
$8.1B
| $2.49M | 0.01% |
133,556
-34,800
| -21% | -$615K |
|
1143
S&P Global
SPGI
$126B
| $2.48M | 0.01% |
14,631
-303,200
| -95% | -$49.5M |
|
1144
Braskem
BAK
$980M
| $2.48M | 0.01% |
94,300
-120,300
| -56% | -$3.44M |
|
|
RDUS
1145
DELISTED
Radius Recycling
RDUS
| $2.48M | 0.01% |
73,866
-70,500
| -49% | -$2.06M |
|
|
OSG
1146
Octave Specialty Group
OSG
$252M
| $2.47M | 0.01% |
+154,838
| New | +$2.38M |
|
1147
National CineMedia
NCMI
$354M
| $2.47M | 0.01% |
35,979
-16,579
| -32% | -$1.1M |
|
1148
Interactive Brokers
IBKR
$40.9B
| $2.46M | 0.01% |
166,364
| – | – |
|
|
ZVO
1149
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.46M | 0.01% |
296,596
+190,038
| +178% | +$1.76M |
|
|
CCEC
1150
Capital Clean Energy Carriers
CCEC
$1.4B
| $2.46M | 0.01% |
104,631
+20,157
| +24% | +$474K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.